Analystreport

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) was downgraded by analysts at TheStreet from a "b-" rating to a "c+" rating.

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com